Unknown

Dataset Information

Exploring small molecules with pan-genotypic inhibitory activities against hepatitis C virus NS3/4A serine protease.


ABSTRACT: Among the many Hepatitis C virus (HCV) genotypes and subtypes, genotypes 1b and 3a are most prevalent in United States and Asia, respectively. A total of 132 commercially available analogs of a previous lead compound were initially investigated against wild-type HCV genotype 1b NS3/4A protease. Ten compounds showed inhibitory activities (IC50 values) below 10 µM with comparable direct binding affinities (KD values) determined by surface plasmon resonance (SPR). To identify pan-genotypic inhibitors, these ten selected compounds were tested against four additional genotypes (1a, 2a, 3a, and 4) and three drug-resistant mutants (A156S, R155K, and V36M). Four new analogs have been identified with better activities against all five tested genotypes than the prior lead compo

SUBMITTER: Ren J 

PROVIDER: S-EPMC6690791 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature